SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193805-20-001473
Filing Date
2020-11-25
Accepted
2020-11-25 19:51:58
Documents
1
Period of Report
2020-11-23

Document Format Files

Seq Description Document Type Size
1 e620105_4-powell.html 4  
1 e620105_4-powell.xml 4 19105
  Complete submission text file 0001193805-20-001473.txt   20640
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Issuer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address
Powell David Jonathan (Reporting) CIK: 0001824493 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36866 | Film No.: 201352475